 This retrospective study found that there was no statistical difference in perioperative characteristics, fusion rates, patient-reported outcome measures, PROMs, or minimal clinically important difference, MCID, achievement between obese patients who received minimally invasive transferaminal lumbar interbody fusion, MIST-LIF, and anterior lumbar interbody fusion, ALIF. Additionally, the study found that obese patients who underwent ALIF had higher PROMS-PF scores at 6 weeks and 12 weeks after surgery, but this did not translate into any significant differences in fusion rates or MCID achievement. This article was authored by Madhav Rajesh Patel, Kevin Chaco Jacob, Cameron Zamanian, and others.